SWA
Sutton Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5
| Closed | -$1K | – | 1659 |
|
|
2022
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1296 |
|
|
2022
Q2 | – | Sell |
-8
| Closed | -$1.31K | – | 1640 |
|
|
2022
Q1 | $1.31K | Buy |
+8
| New | +$1.31K | ﹤0.01% | 1274 |
|
|
2019
Q2 | – | Sell |
-7
| Closed | -$654 | – | 1164 |
|
|
2019
Q1 | $654 | Sell |
7
-134
| -95% | -$12.5K | ﹤0.01% | 1139 |
|
|
2018
Q4 | $10.3K | Buy |
141
+1
| +0.7% | +$73 | 0.01% | 738 |
|
|
2018
Q3 | $12.3K | Buy |
140
+3
| +2% | +$263 | 0.01% | 747 |
|
|
2018
Q2 | $13.5K | Hold |
137
| – | – | 0.01% | 748 |
|
|
2018
Q1 | $16.3K | Sell |
137
-69
| -33% | -$8.22K | 0.01% | 649 |
|
|
2017
Q4 | $26.2K | Buy |
206
+69
| +50% | +$8.77K | 0.02% | 458 |
|
|
2017
Q3 | $16.1K | Hold |
137
| – | – | 0.01% | 615 |
|
|
2017
Q2 | $10.9K | Buy |
+137
| New | +$10.9K | 0.01% | 727 |
|
|
2016
Q4 | – | Sell |
-112
| Closed | -$7.59K | – | 1061 |
|
|
2016
Q3 | $7.59K | Buy |
+112
| New | +$7.59K | 0.01% | 731 |
|
|
2016
Q2 | – | Sell |
-170
| Closed | -$10.7K | – | 1025 |
|
|
2016
Q1 | $10.7K | Buy |
+170
| New | +$10.7K | 0.01% | 598 |
|